©The Author(s) 2025.
World J Gastrointest Oncol. Dec 15, 2025; 17(12): 110395
Published online Dec 15, 2025. doi: 10.4251/wjgo.v17.i12.110395
Published online Dec 15, 2025. doi: 10.4251/wjgo.v17.i12.110395
Figure 3 Pooled risk ratios of cancer-associated fibroblast expression for clinicopathological characteristics in liver cancer patients.
A: Tumor size; B: Venous infiltration; C: Tumor-node-metastasis stage; D: Alpha-fetoprotein level; E: Tumor differentiation. CAF: Cancer-associated fibroblast; LC: Liver cancer; HCC: Hepatocellular carcinoma; iCCA: Intrahepatic cholangiocarcinoma; OR: Odds ratio; CI: Confidence interval.
- Citation: Wei YH, Jiang WJ, Wang SQ, Cai YL, Ma XL. Cancer-associated fibroblasts, clinicopathological characteristics and prognosis of liver cancer: A systematic review and meta-analysis based on real-world research. World J Gastrointest Oncol 2025; 17(12): 110395
- URL: https://www.wjgnet.com/1948-5204/full/v17/i12/110395.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i12.110395